The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Association of Cholesteryl Ester Transfer Protein– Taq IB Polymorphism With Variations in Lipoprotein Subclasses and Coronary Heart Disease Risk: The Framingham Study
Abstract
Abstract —Cholesteryl ester transfer protein (CETP) facilitates the exchange of triglycerides and cholesteryl esters between lipoprotein particles, a key step in reverse cholesterol transport in humans. Variations at the CETP locus have been shown to be determinants of the levels and activity of CETP and high density lipoprotein (HDL) plasma concentration. The associations of the common CETP polymorphism, Taq IB in intron 1, with lipoprotein levels and particle size distribution, CETP activity, and coronary heart disease (CHD) risk were examined in a population-based sample of 1411 men and 1505 women from the Framingham Offspring Study. The B2 allele frequency was 0.444 in men and 0.433 in women, and its presence was significantly ( P <0.05) associated with decreased CETP activity. B1B1 men had lower HDL cholesterol (HDL-C) levels (1.07 mmol/L) compared with B1B2 (1.14 mmol/L) and B2B2 (1.18 mmol/L) men ( P <0.001). Likewise, B1B1 women had lower HDL-C levels (1.40 mmol/L) compared with B1B2 (1.46 mmol/L) and B2B2 (1.53 mmol/L) women ( P <0.001). In men, the B2 allele was associated with increased particle size for HDL and low density lipoprotein. In women, a similar effect was demonstrated only for HDL particle size. The odds ratio for prevalent CHD associated with the B2 allele was 0.696 ( P =0.035) in men. After adjusting for age, body mass index, systolic blood pressure, diabetes, smoking, alcohol consumption, β-blocker use, total cholesterol, and HDL-C, this odds ratio was 0.735 ( P =0.187), suggesting that the protective effect of the B2 allele was due in part to its association with HDL-C levels. No significant protective effects were observed in women. These data demonstrate that variation at the CETP gene locus is a significant determinant of HDL-C levels, CETP activity, and lipoprotein size in this population. Moreover, these effects appear to translate into a lower CHD risk among those men with the B2 allele.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Multipoint Quantitative-Trait Linkage Analysis in General Pedigrees
Almasy, L., & Blangero, J. (1998) · The American Journal of Human Genetics · doi:10.1086/301844 · Cited by 3,028
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,159
Epidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
KANNEL, W. B., FEINLEIB, M., McNAMARA, P. M., GARRISON, R. J., & CASTELLI, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,645
High-Density Lipoprotein — The Clinical Implications of Recent Studies
Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547
Stampfer, M. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110036029 · Cited by 1,079
Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study
Manninen, V. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410050061031 · Cited by 957
The framingham offspring study. Design and preliminary data
Feinleib, M., Kannel, W. B., Garrison, R. J., McNamara, P. M., & Castelli, W. P. (1975) · Preventive Medicine · doi:10.1016/0091-7435(75)90037-7 · Cited by 930
Inazu, A., Brown, M. L., Hesler, C. B., Agellon, L. B., Koizumi, J., Takata, K., Maruhama, Y., Mabuchi, H., & Tall, A. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231803 · Cited by 861
Gardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843
Kuivenhoven, J. A., Jukema, J. W., Zwinderman, A. H., de Knijff, P., McPherson, R., Bruschke, A. V. G., Lie, K. I., & Kastelein, J. J. P. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380203 · Cited by 625
Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions
McNamara, J. R., & Schaefer, E. J. (1987) · Clinica Chimica Acta · doi:10.1016/0009-8981(87)90188-4 · Cited by 521
Self-citationOtvos, J. D., Jeyarajah, E. J., Bennett, D. W., & Krauss, R. M. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.9.1632 · Cited by 420
Self-citationHandbook of Lipoprotein Testing
Rifai, N., Warnick, G. R., & Dominiczak, M. H. (2001) · Medical Entomology and Zoology · Cited by 384
Cloning and sequencing of human cholesteryl ester transfer protein cDNA
Drayna, D., Jarnagin, A. S., McLean, J., Henzel, W., Kohr, W., Fielding, C., & Lawn, R. (1987) · Nature · doi:10.1038/327632a0 · Cited by 350
Fumeron, F., Betoulle, D., Luc, G., Behague, I., Ricard, S., Poirier, O., Jemaa, R., Evans, A., Arveiler, D., & Marques-Vidal, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118207 · Cited by 301
PLASMA LIPID TRANSFER PROTEINS, HIGH-DENSITY LIPOPROTEINS, AND REVERSE CHOLESTEROL TRANSPORT
Bruce, C., Chouinard, R. A., & Tall, A. R. (1998) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.18.1.297 · Cited by 258
(1988) · PubMed · Cited by 250
Inazu, A., Jiang, X. C., Haraki, T., Yagi, K., Kamon, N., Koizumi, J., Mabuchi, H., Takeda, R., Takata, K., & Moriyama, Y. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117537 · Cited by 247
Jiang, X. C., Agellon, L. B., Walsh, A., Breslow, J. L., & Tall, A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115993 · Cited by 223
Kuivenhoven, J. A., de Knijff, P., Boer, J. M. A., Smalheer, H. A., Botma, G.-J., Seidell, J. C., Kastelein, J. J. P., & Pritchard, P. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.3.560 · Cited by 210
Long- and short-term risk of sudden coronary death.
Cupples, L. A., GAGNON, D. R., & Kannel, W. B. (1992) · PubMed · Cited by 198
Self-citationFreeman, D. J., Griffin, B. A., Holmes, A. P., Lindsay, G. M., Gaffney, D., Packard, C. J., & Shepherd, J. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.3.336 · Cited by 188
Kondo, I., Berg, K., Drayna, D., & Lawn, R. (1989) · Clinical Genetics · doi:10.1111/j.1399-0004.1989.tb02904.x · Cited by 178
Hannuksela, M. L., Liinamaa, J., Kesäniemi, Y. A., & Savolainen, M. J. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90065-5 · Cited by 138
Gudnason, V. G., Kakko, S., Nicaud, V., Savolainen, M. J., Kesäniemi, Y. A., Tahvanainen, E., Humphries, S. E., & On Behalf Of The Ears Group (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00412.x · Cited by 132
Enzyme-linked immunosorbent assay for human plasma apolipoprotein B
Ordovás, J. M., Peterson, J., Santaniello, P., Cohn, J. S., Wilson, P. W. F., & Schaefer, E. J. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38611-9 · Cited by 119
Self-citationKauma, H., Savolainen, M. J., Heikkilä, R., Rantala, A. O., Lilja, M., Reunanen, A., & Kesäniemi, Y. A. (1996) · Human Genetics · doi:10.1007/bf02265258 · Cited by 95
Freeman, D. J., Packard, C. J., Shepherd, J., et al. (1990) · Clinical Science · doi:10.1042/cs0790575 · Cited by 90
KOIZUMI, J., Inazu, A., Yagi, K., Koizumi, I., Uno, Y., Kajinami, K., Miyamoto, S., Moulin, P., Tall, A. R., & Mabuchi, H. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90114-i · Cited by 88
Metabolism of apolipoproteins A-I, A-II, and A-IV
Schaefer, E. J., & Ordovás, J. M. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(86)29083-7 · Cited by 77
Self-citationCholesteryl ester transfer protein: friend or foe?
Fielding, C. J., & Havel, R. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118719 · Cited by 63
Tenkanen, H., Koskinen, P., KONTULA, K. K., Aalto‐Setälä, K., M�ntt�ri, M., Manninen, V., Runeberg, S.-L., Taskinen, M., & Ehnholm, C. (1991) · Human Genetics · doi:10.1007/bf00209015 · Cited by 61
Bernard, S., Moulin, P., Lagrost, L., Picard, S., Elchebly, M., Ponsin, G., Chapuis, F. R., & Berthézène, F. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34203-6 · Cited by 54
Clinical significance of lipoprotein size and risk for coronary atherosclerosis
Roheim, P. S., & Asztalos, B. F. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.1.147 · Cited by 47
Molecular genetics of plasma cholesteryl ester transfer protein
Yamashita, S., Sakai, N., Hirano, K., et al. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199704000-00008 · Cited by 37
HDL Heterogeneity and Atherosclerosis
Tailleux, A., Fruchart, J., & Parkes, J. G. (1996) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369609083060 · Cited by 29
Low-density and high-density lipoprotein subspecies and risk for premature coronary artery disease
Brunzell, J. D., & Hokanson, J. E. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00139-4 · Cited by 24
Mutations in cholesteryl ester transfer protein and hepatic lipase in a North American population
Hill, S., Nazir, D. J., Jayaratne, P., Bamford, K. S., & McQueen, M. (1997) · Clinical Biochemistry · doi:10.1016/s0009-9120(97)00009-x · Cited by 23
Tamminen, M., Kakko, S., Kesäniemi, Y. A., & Savolainen, M. J. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05833-9 · Cited by 20
Cholesterol Ester Transfer Protein: A Molecule with Three Faces?
Stevenson, C. G. (1998) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408369891234264 · Cited by 14
Cited by
Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis
Barter, P. J., Brewer, H. B., Chapman, M. J., Hennekens, C. H., Rader, D. J., & Tall, A. R. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000054658.91146.64 · Cited by 870
Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol
Brousseau, M. E., Schaefer, E. J., Wolfe, M. L., Bloedon, L. T., Digenio, A. G., Clark, R. W., Mancuso, J. P., & Rader, D. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031766 · Cited by 774
Self-citationvon Eckardstein, A., Nofer, J.-R., & Assmann, G. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.1.13 · Cited by 695
Smith, G. D., Lawlor, D. A., Harbord, R., Timpson, N., Day, I., & Ebrahim, S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040352 · Cited by 569
Thompson, A. (2008) · JAMA · doi:10.1001/jama.299.23.2777 · Cited by 497
Metadata
- Authors
- Ordovas, J. M., Cupples, L. A., Corella, D., Otvos, J. D., Osgood, D., Martinez, A., Lahoz, C., Coltell, O., Wilson, P. W. F., & Schaefer, E. J.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2000-05
- Volume
- 20
- Issue
- 5
- Pages
- 1323-1329
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2123337267
- Cited by
- 379
- References
- 45
- FWCI
- 12.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.